Lexeo Therapeutics, Inc. Contracts & Agreements

34 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Third License Agreement, dated April 21, 2024, by and between Cornell University and the Company
License Agreements
Lexeo Therapeutics, Inc.
Health Care Equipment & Supplies
NY
2024
Employment Agreement, dated April 10, 2024, by and between the Company and Jose Manuel Otero
Employment Agreements
Lexeo Therapeutics, Inc.
2024
2021 Equity Incentive Plan, as amended from time to time and Form of Stock Option Agreement, Early Exercise Notice and Restricted Stock Purchase Agreement, and Exercise Notice
Bonus & Incentive Agreements
Lexeo Therapeutics, Inc.
2024
Amendment No. 3, dated February 11, 2024, to the First License Agreement, dated May 28, 2020, by and between LEXEO Therapeutics, Inc. and Cornell University (as amended by...
License Agreements
Lexeo Therapeutics, Inc.
2024
Employment Agreement, dated February 2, 2024, by and between the Company and Sandi See Tai, M.D
Employment Agreements
Lexeo Therapeutics, Inc.
2024
Employment Agreement, dated February 3, 2024, by and between the Company and Eric Adler, M.D
Employment Agreements
Lexeo Therapeutics, Inc.
2024
Form of Registration Rights Agreement, dated March 11, 2024
Registration Rights Agreements
Lexeo Therapeutics, Inc.
2024
Description of Securities of the Registrant
Lexeo Therapeutics, Inc.
2024
Form of Common Stock Purchase Agreement, dated March 11, 2024
Stock Agreements
Lexeo Therapeutics, Inc.
2024
2023 Employee Stock Purchase Plan
Stock Agreements
Lexeo Therapeutics, Inc.
2023
2023 Equity Incentive Plan and Forms of Option Grant Notice and Agreement, Exercise Notice and Restricted Stock Unit Award Notice
Bonus & Incentive Agreements
Lexeo Therapeutics, Inc.
2023
Form of Common Stock Certificate of the Registrant
Stock Agreements
Lexeo Therapeutics, Inc.
2023
Form of Underwriting Agreement
Underwriting Agreements
Lexeo Therapeutics, Inc.
2023
Amendment No. 1, dated July 4, 2022, to the First License Agreement, dated May 28, 2020, by and between LEXEO Therapeutics, Inc. and Cornell University and Amendment No. 2, dated...
License Agreements
Lexeo Therapeutics, Inc.
2023
License Agreement, dated January 19, 2021, between Adverum Biotechnologies, Inc. and LEXEO Therapeutics, Inc., as amended by the First Amendment, dated February 28, 2022
License Agreements
Lexeo Therapeutics, Inc.
2023
Research Collaboration Agreement, dated February 3, 2021, by and between Cornell University and LEXEO Therapeutics, Inc. as amended by Amendment No. 1, dated February 1, 2022
Collaboration Agreements
Lexeo Therapeutics, Inc.
2023
Amendment No. 2, dated September 28, 2022, to the First License Agreement, dated May 28, 2020, by and between LEXEO Therapeutics, Inc. and Cornell University (as amended by...
License Agreements
Lexeo Therapeutics, Inc.
2023
License Agreement, dated October 4, 2021, by and between LEXEO Therapeutics, Inc. and the Regents of the University of California
License Agreements
Lexeo Therapeutics, Inc.
2023
2021 Equity Incentive Plan, as amended from time to time and Form of Stock Option Agreement, Early Exercise Notice and Restricted Stock Purchase Agreement, and Exercise Notice
Bonus & Incentive Agreements
Lexeo Therapeutics, Inc.
2023
Form of Indemnification Agreement with Executive Officers and Directors
Indemnification Agreements
Lexeo Therapeutics, Inc.
2023
Amended and Restated Employment Agreement, dated September 28, 2023, by and between the Company and R. Nolan Townsend
Employment Agreements
Lexeo Therapeutics, Inc.
2023
Amended and Restated Employment Agreement, dated September 28, 2023, by and between the Company and Jenny R. Robertson
Employment Agreements
Lexeo Therapeutics, Inc.
2023
Amended and Restated Employment Agreement, dated September 28, 2023, by and between the Company and Paul McCormac
Employment Agreements
Lexeo Therapeutics, Inc.
2023
Consulting Agreement, dated October 9, 2020, between LEXEO Therapeutics, LLC and Ronald G. Crystal, M.D
Consulting Agreements
Lexeo Therapeutics, Inc.
2023
Consulting Agreement, dated July 16, 2021, between LEXEO Therapeutics, LLC and Eric Adler, M.D
Consulting Agreements
Lexeo Therapeutics, Inc.
2023
Stock Purchase Agreement, dated July 16, 2021, by and among LEXEO Therapeutics, Inc., Stelios Therapeutics, Inc., The Cystinosis Research Foundation, Eric Adler, M.D., Farah...
Stock Agreements
Lexeo Therapeutics, Inc.
2023
Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated August 10, 2021
Investor Rights Agreements
Lexeo Therapeutics, Inc.
2023
License Agreement, dated April 23, 2020, by and between Stelios Therapeutics, Inc. (as successor-in-interest to ARVC Therapeutics, Inc.) and the Regents of the University of...
License Agreements
Lexeo Therapeutics, Inc.
2023
License Agreement, dated August 6, 2020, by and between Stelios Therapeutics, Inc. and the Regents of the University of California
License Agreements
Lexeo Therapeutics, Inc.
2023
ARVC Research Agreement, dated December 3, 2021, between LEXEO Therapeutics, Inc. and the Regents of the University of California, as amended by Amendment No. 1, dated April 5,...
Lexeo Therapeutics, Inc.
2023
TNNI3 Research Agreement, dated December 3, 2021, between LEXEO Therapeutics, Inc. and the Regents of the University of California, as amended by Amendment No. 1, dated April 19,...
Lexeo Therapeutics, Inc.
2023
First License Agreement, dated May 28, 2020, between LEXEO Therapeutics, LLC and Cornell University
License Agreements
Lexeo Therapeutics, Inc.
2023
Second License Agreement, dated May 28, 2020, between LEXEO Therapeutics, LLC and Cornell University
License Agreements
Lexeo Therapeutics, Inc.
2023
Amendment No. 1, dated January 13, 2022, to the Second License Agreement, dated May 28, 2020, by and between LEXEO Therapeutics, Inc. and Cornell University
License Agreements
Lexeo Therapeutics, Inc.
2023